Exagen, Inc. (XGN)
7.88
+0.47
(+6.34%)
USD |
NASDAQ |
Oct 21, 16:00
7.77
-0.11
(-1.40%)
After-Hours: 20:00
Exagen Net Income (Annual) : -19.95M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -19.95M |
| December 31, 2024 | -15.12M |
| December 31, 2023 | -23.69M |
| December 31, 2022 | -47.39M |
| December 31, 2021 | -26.85M |
| December 31, 2020 | -16.69M |
| December 31, 2019 | -25.64M |
| Date | Value |
|---|---|
| December 31, 2018 | -9.164M |
| December 31, 2017 | -27.42M |
| December 31, 2015 | -19.18M |
| December 31, 2014 | -14.98M |
| December 31, 2013 | -13.50M |
| December 31, 2012 | -7.324M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Myriad Genetics, Inc. | -365.90M |
| BioRestorative Therapies, Inc. | -14.24M |
| CareDx, Inc. | -21.35M |
| Natera, Inc. | -208.16M |
| Sera Prognostics, Inc. | -31.93M |